期刊文献+

白血病患儿造血干细胞移植后发生眼Kaposi肉瘤一例报告附文献复习 被引量:4

Acute leukemia child with ocular Kaposi' s sarcoma after hematopoietic stem cell transplantation : a case report and literatures review
原文传递
导出
摘要 目的探讨白血病患儿造血干细胞移植后眼卡波西肉瘤(Kaposi’Ssarcoma,KS)的临床特征。方法回顾性分析1例HIV阴性急性淋巴细胞白血病(ALL)患儿非血缘相关外周血干细胞移植(PBSCT)后发生单眼角膜、结膜及巩膜Ks的临床资料。结果患儿为高危T细胞型ALL,接受PBSCT后7个月出现右眼视物模糊,缓慢进展为角结膜新生物。病理表现为毛细血管瘤样改变及异型性梭形细胞,结合典型免疫组化及原位杂交人类疱疹病毒8型(HHV8)阳性,诊断为右眼Ks。行角结膜巩膜肿物切除及角膜巩膜移植术,予抗病毒、抗感染、促修复、增强免疫力、预防角膜排斥等治疗,右眼保留且有手动视力,原发病未复发,未发生移植物抗宿主病。结论首次报告国内ALL患儿造血干细胞移植后发生与HIV感染无关眼KS。手术及生物治疗对眼KS是一种安全有效的方法。 Objective To summarize clinical features of eye Kaposis' sarcoma ( KS ) in leukemia child after peripheral blood stem cell transplantation (PBSCT). Methods One 13 years-old child with acute lymphoblastic leukemia (ALL) and negative HIV test who developed KS restricted in right conjunctiva, cornea and sclera after successful allogeneic PBSCT was reviewed retrospectively. Results The child suffered from T cell type ALL. He received immunosuppressive treatment after PBSCT, and had once extensive herpes zoster restricted in skin. Seven months after PBSCT, he had blurred vision with right eye and slowly neoplasm formed in cornea and conjunctiva. Pathological examination confirmed KS with changes like capillary hemangioma, atypical fusifol^n cell, typical immunochemistry and positive immunofluorescent result of HHV8. He received excision of lump of cornea, conjunctiva, sclera and transplantation of cornea and sclera. Antiviral therapy was given together with anti-infection, prevention of cornea rejection and biotherapy. He kept right eye and hand-move eyesight, survived without GVHD or recurrence of ALL and KS. Conclusion This was the first ocular KS case in ALL child after PBSCT, without correlation with HIV infection. Complete excision combined with biotherapy was safe and effective for single ocular lesions.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2013年第5期445-448,共4页 Chinese Journal of Hematology
关键词 卡波西肉瘤 白血病 淋巴细胞 急性 造血干细胞移植 Kaposis ' sarcoma Leukemia, lymphoblastic, acute Hematopoietic stem celltransplantation
  • 相关文献

参考文献15

  • 1方建培,陈纯,金润铭.儿童白血病的诊断和治疗.1版.北京:人民卫生出版社,2008:149-150.
  • 2Douglas JL, Gustin JK, Dezube B, et al. Kaposi sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med, 2007, 49 : 119-138.
  • 3Sudzinski J, Thomas F, Berthout A, et al. Conjunctival Kaposi sarcoma. J Fr Ophtalmol,2009, 32 : 151-155.
  • 4Dietrich-Ntoukas T, Cursiefen C, Westekemper H, et al. Diagno- sis and treatment of ocular chronic graft-versus-host disease : reportfrom the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea, 2012,31:299-310.
  • 5Kocsard E. Kaposi sarcoma in a Chinese boy( aged 16 years) with localisation on the left lower extremity and on the right caruncula lacrimalis. Dermatologica, 1949, 99:43-48.
  • 6Weiter JJ, Jakobiec FA, Iwamoto T. The clinical and morphologic characteristics of Kaposi sarcomas of the conjunctiva. Am J Ophthalmol, 1980,89:546-552.
  • 7Curtis TH, Durairaj VD. Conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. Ophthal Plast Reconstr Surg,2005, 21:314-315.
  • 8Minoda H, Usui N, Sata T, et al. Human herpesvirus-8 in Kaposi sarcoma of the conjunctiva in a patient with AIDS. Jpn J Ophthalmo1,2006, 50:7-11.
  • 9Reiser BJ, Mok A, Kukes G, et al. Non-AIDS-related Kaposi sarcoma involving the tarsal conjunctiva and eyelid margin. Arch Ophthalmol,2007, 125:838-840.
  • 10Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med,2003,9:554-561.

同被引文献67

  • 1文海泉,周英,朱娇媛.肾移植后发生Kaposi肉瘤一例[J].中华皮肤科杂志,2003,36(7):374-374. 被引量:2
  • 2陈宁,甄泽年,余英豪.免疫抑制剂致咽部Kaposi肉瘤1例[J].临床耳鼻咽喉科杂志,1996,10(4):240-240. 被引量:1
  • 3朱凌峰,杨顺良.肾移植术后并发Kaposi肉瘤一例[J].中华器官移植杂志,2006,27(1):35-35. 被引量:2
  • 4肖汀,何春涤,林俊萍,王雅坤,李波,陈洪铎.免疫抑制型Kaposi肉瘤1例[J].中国麻风皮肤病杂志,2006,22(6):506-507. 被引量:1
  • 5韩澍,王亚伟,朱有华,王立明.肾移植术后并发卡波西肉瘤一例报告[J].第二军医大学学报,2007,28(7):708-708. 被引量:6
  • 6Pui CH, Mullighan CG, Evans WE, et al. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? [-J]. Blood,2012,120(6) : 1165-1174.
  • 7Hunger SP, Loh ML, Whitlock JA, et al. Children's Oncology Group's 2013 blueprint for research., acute lymphoblastic leukemia [J]. Pediatr Blood Cancer, 2013,60(6) :957-963.
  • 8Ko RH, Ji L, Barnette P, et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study I-J3. J Clin Oncol,2010,28(4) :648-654.
  • 9Malempati S, Gaynon PS, Sather H,et al. Children's Oneology Group outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952[J]. J Clin Oncol, 2007,25(36) :5800-5807.
  • 10Einsiedel HG, yon Staekelberg A, Hartmann R,et al. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87[J]. J Clin Oncol, 2005,23(31) : 7942-7950.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部